SpringWorks Therapeutics Statistics
Total Valuation
BOM:500178 has a market cap or net worth of INR 22.79 million. The enterprise value is 745.66 million.
Market Cap | 22.79M |
Enterprise Value | 745.66M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BOM:500178 has 10.50 million shares outstanding. The number of shares has increased by 166.06% in one year.
Current Share Class | 10.50M |
Shares Outstanding | 10.50M |
Shares Change (YoY) | +166.06% |
Shares Change (QoQ) | -0.23% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.37 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -20.67 |
Financial Position
The company has a current ratio of 7.52
Current Ratio | 7.52 |
Quick Ratio | 0.12 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -20.07 |
Interest Coverage | -0.34 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -4.76% |
Return on Invested Capital (ROIC) | -7.94% |
Return on Capital Employed (ROCE) | -21.83% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 1,504 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -23.57M |
Pretax Income | -543.34M |
Net Income | -543.34M |
EBITDA | -20.91M |
EBIT | -23.57M |
Earnings Per Share (EPS) | -51.78 |
Balance Sheet
The company has 1.21 million in cash and 724.09 million in debt, giving a net cash position of -722.88 million or -68.85 per share.
Cash & Cash Equivalents | 1.21M |
Total Debt | 724.09M |
Net Cash | -722.88M |
Net Cash Per Share | -68.85 |
Equity (Book Value) | -614.25M |
Book Value Per Share | -58.54 |
Working Capital | 63.20M |
Cash Flow
In the last 12 months, operating cash flow was -26.98 million and capital expenditures -9.10 million, giving a free cash flow of -36.08 million.
Operating Cash Flow | -26.98M |
Capital Expenditures | -9.10M |
Free Cash Flow | -36.08M |
FCF Per Share | -3.44 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BOM:500178 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -166.06% |
Shareholder Yield | n/a |
Earnings Yield | -2,384.64% |
FCF Yield | -158.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2024. It was a reverse split with a ratio of 0.01.
Last Split Date | Jul 12, 2024 |
Split Type | Reverse |
Split Ratio | 0.01 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |